CCI vs NAMSW
Crown Castle (CCI) versus NewAmsterdam Pharma Company N.V. Warrant (NAMSW) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) common stock listed on NASDAQ.
Latest reported CCI revenue for 2026-06-30 was $2.02B. Net income was $245.0M. Revenue was up 99.8% from 2026-03-31 to 2026-06-30. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
NAMSW does not have a complete income-statement cache yet.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. NAMSW currently screens at market cap $0.
Not investment advice. Open the CCI and NAMSW stock pages for the full models.
Not investment advice.